Biofrontera (BFRI) FCF Margin (2020 - 2025)
Biofrontera (BFRI) recorded quarterly FCF Margin of 14.12% in Q4 2025, up 73.93% quarter-over-quarter from 54.15% in Q3 2025, and down 634.0% on a YoY basis from 2.64% in Q4 2024.
Biofrontera (BFRI) FCF Margin (2020 - 2025) Analysis & Trends
Biofrontera's FCF Margin history runs 6 years deep, the most recent figure standing at 14.12% for Q4 2025.
- In Q4 2025, FCF Margin fell 634.0% year-over-year to 14.12%; the TTM figure through Dec 2025 stood at 32.13% (down 459.0% YoY), while the FY2025 annual figure was 32.14%, down 459.0% from the prior year.
- FCF Margin was 14.12% for Q4 2025 at Biofrontera, up from 54.15% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2.11% in Q2 2022 to a low of 229.05% in Q4 2021.
- Historically, FCF Margin has averaged 59.31% across 5 years, with a median of 42.64% in 2023.
- The sharpest annual moves came in 2021 and 2022: FCF Margin plunged 22095 bps in 2021, then soared 14749 bps in 2022.
- A 5-year view of FCF Margin shows it stood at 229.05% in 2021, then soared by 64 bps to 81.56% in 2022, then decreased by 3 bps to 83.64% in 2023, then soared by 91 bps to 7.78% in 2024, then tumbled by 81 bps to 14.12% in 2025.
- The last three FCF Margin figures came in at 14.12% (Q4 2025), 54.15% (Q3 2025), and 34.34% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | -14.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.12% |
| Sep 30, 2025 | -54.15% |
| Jun 30, 2025 | -34.34% |
| Mar 31, 2025 | -47.78% |
| Dec 31, 2024 | -7.78% |
| Sep 30, 2024 | -13.40% |
| Jun 30, 2024 | -60.12% |
| Mar 31, 2024 | -42.75% |
| Dec 31, 2023 | -83.64% |
| Sep 30, 2023 | -22.53% |
| Jun 30, 2023 | -176.56% |
| Mar 31, 2023 | -42.53% |
| Dec 31, 2022 | -81.56% |
| Sep 30, 2022 | -137.48% |
| Jun 30, 2022 | 2.11% |
| Mar 31, 2022 | -21.71% |
| Dec 31, 2021 | -229.05% |
| Sep 30, 2021 | -28.24% |
| Jun 30, 2021 | -18.05% |
| Mar 31, 2021 | -72.58% |